TSX closed
Loading markets…

Advertisement

Stocks

What's Going On With A-Labs Capital II Corp Stock Friday?

By Wealth Awesome -

Follow live quotes and coverage.

Stocks & ETFs:ALAB-P.V

Get ALAB-P alerts:

Photos provided by Pexels

A-Labs Capital II Corp's stock has remained stable this week, reflecting a cautious approach from investors amid ongoing developments.

This week, A-Labs Capital II Corp (ALAB-P.V) has seen no movement in its stock price, with shares closing at C$0.06. The company continues its efforts to stabilize and grow following recent corporate activities, but investor sentiment remains muted as evidenced by low trading volumes.

Advertisement

A-Labs Capital II Corp

ALAB-P.V

Full stock page →

ALAB-P.V

A-Labs Capital II Corp

Source:WealthAwesomeWealthAwesome
$0.06 (-50.00%)
120 day period
$0.04$0.08$0.11Jan 13Apr 15Sep 9

Market cap

$426,959

52W high

$0.15

52W low

$0.04

1W change

+0.00%

Beta

-0.21

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on ALAB-P's historical volatility

HistoricalForecast68%95%
C$0.00C$0.24C$0.49C$0.73C$0.97C$1.21TodayFeb 27May 6Sep 9Oct 22Dec 5Jan 17

30-Day Vol

267.1%

Annualized

90-Day Vol

153.3%

Annualized

Trend (90d)

-36.5%

Annualized drift

90d Mean

C$0.05

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.05C$0.02C$0.13
60 trading daysC$0.05C$0.01C$0.19
90 trading daysC$0.05C$0.01C$0.24

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Investor takeaway: With no significant news impacting the stock this week, investors may want to monitor A-Labs Capital's ongoing developments, including its recent private placement and corporate updates, as the company navigates its financial landscape.

A-Labs Capital II Corp has a market cap of C$426,959.

With a market cap under C$500,000, A-Labs Capital is classified as a micro-cap stock, which often carries higher risks and volatility for investors.

Bull case

The completion of the first tranche of a private placement could provide A-Labs Capital with the funds it needs to support operations and future growth initiatives. If shareholders approve corporate matters during the AGM, it may signal stability and support for management's strategies.

Bear case

Despite recent fundraising efforts, A-Labs Capital's financial health is concerning due to its negative profit margin and return on equity. The lack of trading activity may indicate investor hesitance, and the stock's performance has been lackluster year-to-date.

Recent Price Action

A-Labs Capital II Corp's stock closed at C$0.06 on Friday, with no change in price over the past week. Year-to-date, the stock has decreased by 8.33%. The trading volume for the day was 3,000 shares, significantly lower than the 20-day average of 13,669 shares, indicating a lack of investor interest.

Advertisement

Company News and Developments

This week, A-Labs Capital has not released any major news that would impact its stock performance. However, recent headlines include the completion of a private placement that raised $100,000 and the results from the annual general meeting where shareholders approved all presented matters. These developments may provide a foundation for future growth, but they have not yet translated into increased trading activity.

Technical Picture

From a technical perspective, A-Labs Capital's stock is currently trading below both its 50-day moving average of C$0.06 and its 200-day moving average of C$0.07. The stock has a 52-week range of C$0.04 to C$0.15, indicating it is currently at about 10% of its range. With a beta of -0.21, the stock has exhibited lower volatility compared to the overall market.

Insider Activity

Recent insider activity includes a subscription of 500,000 units under the private placement by an insider, indicating confidence in the company's future prospects. However, the overall lack of significant insider buying may reflect caution among other insiders.


Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: September 11, 2026
Last Updated: September 11, 2026
PARTNER SPOTLIGHT

Blue Cross Life® Term Life Insurance

Affordable term life coverage in Canada — get a free quote in seconds, no credit card required.

  • Coverage from $100,000 to $5 million, terms of 10–30 years
  • 10% off first-year premiums when couples apply together
  • Fully digital application — many qualify without a medical exam

Sponsored links

Advertisement